Stock ARQT ARCUTIS BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Arcutis Biotherapeutics, Inc.

Equities

ARQT

US03969K1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
8.88 USD -3.06% Intraday chart for Arcutis Biotherapeutics, Inc. -6.33% +174.92%
May. 28 Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion MT
May. 15 Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ARCUTIS BIOTHERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.06%-6.33%+174.92%+5.71% - 1.03B
Neutral
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ARQT Stock
  4. Charts Arcutis Biotherapeutics, Inc.
  5. Comparison Chart